NCT00535171

Venous Thromboembolism Taskforce Audit Program

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 8,764 (actual)
• Sponsor: Sanofi · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To determine the effect of an interventional campaign run by a dedicated "VTE Nurse Educator" over a 6-month period and the effect on prophylaxis rates. To determine the proportion of medically admitted patients with risk factors for VTE. To assess and compare the use of venous thromboembolism (VTE) prophylaxis in hospitalized medical patients versus recommendations and current guidelines. To determine the patient characteristics of those deemed to be at risk of VTE. To determine the proportion of patients receiving appropriate thromboprophylaxis for their risk. To determine the type and duration (where possible) of prophylaxis used.

Conditions

• Venous Thrombosis

Timeline

• Start date: 2007-06-01
• Primary completion: 2008-08-01
• First posted: 2007-09-26
• Last updated: 2010-01-22

Locations

1 site across 1 country: Australia